{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:25:11Z","timestamp":1793237111408,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:00:00Z","timestamp":1606521600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:00:00Z","timestamp":1606521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s11064-020-03186-w","type":"journal-article","created":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T03:02:43Z","timestamp":1606532563000},"page":"513-522","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Idebenone Ameliorates Rotenone-Induced Parkinson\u2019s Disease in Rats Through Decreasing Lipid Peroxidation"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6471-6495","authenticated-orcid":false,"given":"Bahattin","family":"Avc\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8304-832X","authenticated-orcid":false,"given":"Caner","family":"G\u00fcnayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1468-3415","authenticated-orcid":false,"given":"Tolga","family":"G\u00fcven\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2654-8755","authenticated-orcid":false,"given":"Canan Kulcu","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5601-4952","authenticated-orcid":false,"given":"Nilufer","family":"Kuruca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2878-6968","authenticated-orcid":false,"given":"S. Sirri","family":"Bilge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,28]]},"reference":[{"issue":"9680","key":"3186_CR1","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T (2009) Parkinson\u2019s disease. Lancet 373(9680):2055\u20132066. https:\/\/doi.org\/10.1016\/S0140-6736(09)60492-X","journal-title":"Lancet"},{"issue":"1","key":"3186_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1172\/JCI36470","volume":"119","author":"V Brochard","year":"2009","unstructured":"Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V, Bonduelle O, Alvarez-Fischer D, Callebert J, Launay JM, Duyckaerts C, Flavell RA, Hirsch EC, Hunot S (2009) Infiltration of CD4\u2009+\u2009lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Investig 119(1):182\u2013192. https:\/\/doi.org\/10.1172\/JCI36470","journal-title":"J Clin Investig"},{"issue":"2","key":"3186_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascon S, Hatzios SK, Kagan VE, Noel K, Jiang X, Linkermann A, Murphy ME, Overholtzer M, Oyagi A, Pagnussat GC, Park J, Ran Q, Rosenfeld CS, Salnikow K, Tang D, Torti FM, Torti SV, Toyokuni S, Woerpel KA, Zhang DD (2017) Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171(2):273\u2013285. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021","journal-title":"Cell"},{"key":"3186_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ph11040109","author":"MT Nunez","year":"2018","unstructured":"Nunez MT, Chana-Cuevas P (2018) New perspectives in iron chelation therapy for the treatment of neurodegenerative diseases. Pharmaceuticals. https:\/\/doi.org\/10.3390\/ph11040109","journal-title":"Pharmaceuticals"},{"key":"3186_CR5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3389\/fnins.2018.00466","volume":"12","author":"M Abdalkader","year":"2018","unstructured":"Abdalkader M, Lampinen R, Kanninen KM, Malm TM, Liddell JR (2018) Targeting Nrf2 to suppress ferroptosis and mitochondrial dysfunction in neurodegeneration. Front Neurosci 12:466. https:\/\/doi.org\/10.3389\/fnins.2018.00466","journal-title":"Front Neurosci"},{"key":"3186_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neulet.2016.02.011","volume":"617","author":"CC de Farias","year":"2016","unstructured":"de Farias CC, Maes M, Bonifacio KL, Bortolasci CC, de Souza Nogueira A, Brinholi FF, Matsumoto AK, do Nascimento MA, de Melo LB, Nixdorf SL, Lavado EL, Moreira EG, Barbosa DS (2016) Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson\u2019s disease and its progression: disease and staging biomarkers and new drug targets. Neurosci Lett 617:66\u201371. https:\/\/doi.org\/10.1016\/j.neulet.2016.02.011","journal-title":"Neurosci Lett"},{"issue":"8","key":"3186_CR7","doi-asserted-by":"publisher","first-page":"858","DOI":"10.2174\/1568026615666150827095252","volume":"16","author":"X Yang","year":"2016","unstructured":"Yang X, Zhang Y, Xu H, Luo X, Yu J, Liu J, Chang RC (2016) Neuroprotection of coenzyme Q10 in neurodegenerative diseases. Curr Top Med Chem 16(8):858\u2013866. https:\/\/doi.org\/10.2174\/1568026615666150827095252","journal-title":"Curr Top Med Chem"},{"issue":"5","key":"3186_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/10715760600617843","volume":"40","author":"HN Bhagavan","year":"2006","unstructured":"Bhagavan HN, Chopra RK (2006) Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 40(5):445\u2013453. https:\/\/doi.org\/10.1080\/10715760600617843","journal-title":"Free Radic Res"},{"issue":"26","key":"3186_CR9","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.2174\/092986711796957257","volume":"18","author":"D Orsucci","year":"2011","unstructured":"Orsucci D, Mancuso M, Ienco EC, LoGerfo A, Siciliano G (2011) Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues. Curr Med Chem 18(26):4053\u20134064. https:\/\/doi.org\/10.2174\/092986711796957257","journal-title":"Curr Med Chem"},{"key":"3186_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/nano8020087","author":"L Montenegro","year":"2018","unstructured":"Montenegro L, Turnaturi R, Parenti C, Pasquinucci L (2018) Idebenone: novel strategies to improve its systemic and local efficacy. Nanomaterials. https:\/\/doi.org\/10.3390\/nano8020087","journal-title":"Nanomaterials"},{"issue":"2","key":"3186_CR11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s11064-014-1236-z","volume":"39","author":"MA Ahmed","year":"2014","unstructured":"Ahmed MA (2014) Neuroprotective effects of idebenone against pilocarpine-induced seizures: modulation of antioxidant status, DNA damage and Na(+), K (+)-ATPase activity in rat hippocampus. Neurochem Res 39(2):394\u2013402. https:\/\/doi.org\/10.1007\/s11064-014-1236-z","journal-title":"Neurochem Res"},{"key":"3186_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3389\/fncel.2018.00529","volume":"12","author":"A Yan","year":"2018","unstructured":"Yan A, Liu Z, Song L, Wang X, Zhang Y, Wu N, Lin J, Liu Y, Liu Z (2018) Idebenone alleviates neuroinflammation and modulates microglial polarization in LPS-stimulated BV2 cells and MPTP-induced Parkinson\u2019s disease mice. Front Cell Neurosci 12:529. https:\/\/doi.org\/10.3389\/fncel.2018.00529","journal-title":"Front Cell Neurosci"},{"issue":"12","key":"3186_CR13","doi-asserted-by":"publisher","first-page":"e28855","DOI":"10.1371\/journal.pone.0028855","volume":"6","author":"E Gerhardt","year":"2011","unstructured":"Gerhardt E, Graber S, Szego EM, Moisoi N, Martins LM, Outeiro TF, Kermer P (2011) Idebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout mice. PLoS ONE 6(12):e28855. https:\/\/doi.org\/10.1371\/journal.pone.0028855","journal-title":"PLoS ONE"},{"issue":"11","key":"3186_CR14","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1517\/17425255.2010.530656","volume":"6","author":"C Becker","year":"2010","unstructured":"Becker C, Bray-French K, Drewe J (2010) Pharmacokinetic evaluation of idebenone. Expert Opin Drug Metab Toxicol 6(11):1437\u20131444. https:\/\/doi.org\/10.1517\/17425255.2010.530656","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"3186_CR15","doi-asserted-by":"publisher","first-page":"155932581881218","DOI":"10.1177\/1559325818812188","volume":"16","author":"LM Fadda","year":"2018","unstructured":"Fadda LM, Hagar H, Mohamed AM, Ali HM (2018) Quercetin and idebenone ameliorate oxidative stress, inflammation, DNA damage, and apoptosis induced by titanium dioxide nanoparticles in rat liver. Dose Response 16(4):1559325818812188. https:\/\/doi.org\/10.1177\/1559325818812188","journal-title":"Dose Response"},{"key":"3186_CR16","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"2009","unstructured":"Paxinos G, Watson C (2009) The rat brain in stereotaxic coordinates. Elsevier\/Academic, Amsterdam"},{"issue":"1","key":"3186_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2011.03.031","volume":"222","author":"TH Hsieh","year":"2011","unstructured":"Hsieh TH, Chen JJ, Chen LH, Chiang PT, Lee HY (2011) Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion. Behav Brain Res 222(1):1\u20139. https:\/\/doi.org\/10.1016\/j.bbr.2011.03.031","journal-title":"Behav Brain Res"},{"key":"3186_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fnbeh.2013.00175","volume":"7","author":"FL Campos","year":"2013","unstructured":"Campos FL, Carvalho MM, Cristovao AC, Je G, Baltazar G, Salgado AJ, Kim YS, Sousa N (2013) Rodent models of Parkinson\u2019s disease: beyond the motor symptomatology. Front Behav Neurosci 7:175. https:\/\/doi.org\/10.3389\/fnbeh.2013.00175","journal-title":"Front Behav Neurosci"},{"key":"3186_CR19","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.2147\/NDT.S165931","volume":"15","author":"L Tu","year":"2019","unstructured":"Tu L, Wu ZY, Yang XL, Zhang Q, Gu R, Wang Q, Tian T, Yao H, Qu X, Tian JY (2019) Neuroprotective effect and mechanism of baicalin on Parkinson\u2019s disease model induced by 6-OHDA. Neuropsychiatr Dis Treat 15:3615\u20133625. https:\/\/doi.org\/10.2147\/NDT.S165931","journal-title":"Neuropsychiatr Dis Treat"},{"key":"3186_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.neuint.2018.11.005","volume":"122","author":"K Miyanishi","year":"2019","unstructured":"Miyanishi K, Choudhury ME, Watanabe M, Kubo M, Nomoto M, Yano H, Tanaka J (2019) Behavioral tests predicting striatal dopamine level in a rat hemi-Parkinson\u2019s disease model. Neurochem Int 122:38\u201346. https:\/\/doi.org\/10.1016\/j.neuint.2018.11.005","journal-title":"Neurochem Int"},{"issue":"1","key":"3186_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265\u2013275","journal-title":"J Biol Chem"},{"key":"3186_CR22","doi-asserted-by":"publisher","first-page":"113159","DOI":"10.1016\/j.expneurol.2019.113159","volume":"325","author":"DN Koutzoumis","year":"2020","unstructured":"Koutzoumis DN, Vergara M, Pino J, Buddendorff J, Khoshbouei H, Mandel RJ, Torres GE (2020) Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson\u2019s disease. Exp Neurol 325:113159. https:\/\/doi.org\/10.1016\/j.expneurol.2019.113159","journal-title":"Exp Neurol"},{"key":"3186_CR23","doi-asserted-by":"publisher","first-page":"572634","DOI":"10.1155\/2011\/572634","volume":"2011","author":"V Shukla","year":"2011","unstructured":"Shukla V, Mishra SK, Pant HC (2011) Oxidative stress in neurodegeneration. Adv Pharmacol Sci 2011:572634. https:\/\/doi.org\/10.1155\/2011\/572634","journal-title":"Adv Pharmacol Sci"},{"issue":"1","key":"3186_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13041-017-0340-9","volume":"10","author":"L Puspita","year":"2017","unstructured":"Puspita L, Chung SY, Shim JW (2017) Oxidative stress and cellular pathologies in Parkinson\u2019s disease. Mol Brain 10(1):53. https:\/\/doi.org\/10.1186\/s13041-017-0340-9","journal-title":"Mol Brain"},{"issue":"4","key":"3186_CR25","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3892\/ijmm.2018.3406","volume":"41","author":"JD Guo","year":"2018","unstructured":"Guo JD, Zhao X, Li Y, Li GR, Liu XL (2018) Damage to dopaminergic neurons by oxidative stress in Parkinson\u2019s disease (review). Int J Mol Med 41(4):1817\u20131825. https:\/\/doi.org\/10.3892\/ijmm.2018.3406","journal-title":"Int J Mol Med"},{"issue":"34","key":"3186_CR26","doi-asserted-by":"publisher","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","volume":"23","author":"TB Sherer","year":"2003","unstructured":"Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT (2003) Mechanism of toxicity in rotenone models of Parkinson\u2019s disease. J Neurosci 23(34):10756\u201310764","journal-title":"J Neurosci"},{"issue":"3","key":"3186_CR27","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2174\/1570159x13666151030102718","volume":"14","author":"R Filograna","year":"2016","unstructured":"Filograna R, Beltramini M, Bubacco L, Bisaglia M (2016) Anti-oxidants in Parkinson\u2019s disease therapy: a critical point of view. Curr Neuropharmacol 14(3):260\u2013271. https:\/\/doi.org\/10.2174\/1570159x13666151030102718","journal-title":"Curr Neuropharmacol"},{"key":"3186_CR28","doi-asserted-by":"publisher","first-page":"2038267","DOI":"10.1155\/2018\/2038267","volume":"2018","author":"TT Nguyen","year":"2018","unstructured":"Nguyen TT, Vuu MD, Huynh MA, Yamaguchi M, Tran LT, Dang TPT (2018) Curcumin effectively rescued Parkinson\u2019s disease-like phenotypes in a novel drosophila melanogaster model with dUCH knockdown. Oxid Med Cell Longev 2018:2038267. https:\/\/doi.org\/10.1155\/2018\/2038267","journal-title":"Oxid Med Cell Longev"},{"key":"3186_CR29","doi-asserted-by":"publisher","first-page":"8409329","DOI":"10.1155\/2019\/8409329","volume":"2019","author":"SM Dos Santos","year":"2019","unstructured":"Dos Santos SM, Romeiro CFR, Rodrigues CA, Cerqueira ARL, Monteiro MC (2019) Mitochondrial dysfunction and alpha-lipoic acid: beneficial or harmful in Alzheimer\u2019s disease? Oxid Med Cell Longev 2019:8409329. https:\/\/doi.org\/10.1155\/2019\/8409329","journal-title":"Oxid Med Cell Longev"},{"issue":"1\u20132","key":"3186_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10863-014-9571-y","volume":"47","author":"S Jaber","year":"2015","unstructured":"Jaber S, Polster BM (2015) Idebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier? J Bioenerg Biomembr 47(1\u20132):111\u2013118. https:\/\/doi.org\/10.1007\/s10863-014-9571-y","journal-title":"J Bioenerg Biomembr"},{"issue":"1","key":"3186_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40263-013-0124-4","volume":"28","author":"J Liu","year":"2014","unstructured":"Liu J, Wang LN (2014) Mitochondrial enhancement for neurodegenerative movement disorders: a systematic review of trials involving creatine, coenzyme Q10, idebenone and mitoquinone. CNS Drugs 28(1):63\u201368. https:\/\/doi.org\/10.1007\/s40263-013-0124-4","journal-title":"CNS Drugs"},{"issue":"3","key":"3186_CR32","doi-asserted-by":"publisher","first-page":"e17963","DOI":"10.1371\/journal.pone.0017963","volume":"6","author":"RH Haefeli","year":"2011","unstructured":"Haefeli RH, Erb M, Gemperli AC, Robay D, Courdier Fruh I, Anklin C, Dallmann R, Gueven N (2011) NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels. PLoS ONE 6(3):e17963. https:\/\/doi.org\/10.1371\/journal.pone.0017963","journal-title":"PLoS ONE"},{"issue":"2","key":"3186_CR33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson\u2019s disease. J Neurochem 52(2):381\u2013389. https:\/\/doi.org\/10.1111\/j.1471-4159.1989.tb09133.x","journal-title":"J Neurochem"},{"issue":"2","key":"3186_CR34","first-page":"129","volume":"13","author":"J Sanyal","year":"2009","unstructured":"Sanyal J, Bandyopadhyay SK, Banerjee TK, Mukherjee SC, Chakraborty DP, Ray BC, Rao VR (2009) Plasma levels of lipid peroxides in patients with Parkinson\u2019s disease. Eur Rev Med Pharmacol Sci 13(2):129\u2013132","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"3186_CR35","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1248\/bpb1978.8.1006","volume":"8","author":"Y Sugiyama","year":"1985","unstructured":"Sugiyama Y, Fujita T, Matsumoto M, Okamoto K, Imada I (1985) Effects of idebenone (CV-2619) and its metabolites on respiratory activity and lipid peroxidation in brain mitochondria from rats and dogs. J Pharmacobiodyn 8(12):1006\u20131017. https:\/\/doi.org\/10.1248\/bpb1978.8.1006","journal-title":"J Pharmacobiodyn"},{"issue":"3","key":"3186_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0167-4943(89)90010-1","volume":"8","author":"M Suno","year":"1989","unstructured":"Suno M, Nagaoka A (1989) Inhibition of lipid peroxidation by idebenone in brain mitochondria in the presence of succinate. Arch Gerontol Geriatr 8(3):291\u2013297. https:\/\/doi.org\/10.1016\/0167-4943(89)90010-1","journal-title":"Arch Gerontol Geriatr"},{"issue":"4","key":"3186_CR37","doi-asserted-by":"publisher","first-page":"e36153","DOI":"10.1371\/journal.pone.0036153","volume":"7","author":"M Erb","year":"2012","unstructured":"Erb M, Hoffmann-Enger B, Deppe H, Soeberdt M, Haefeli RH, Rummey C, Feurer A, Gueven N (2012) Features of idebenone and related short-chain quinones that rescue ATP levels under conditions of impaired mitochondrial complex I. PLoS ONE 7(4):e36153. https:\/\/doi.org\/10.1371\/journal.pone.0036153","journal-title":"PLoS ONE"},{"issue":"7","key":"3186_CR38","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s00204-015-1517-6","volume":"89","author":"MA Bradley-Whitman","year":"2015","unstructured":"Bradley-Whitman MA, Lovell MA (2015) Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update. Arch Toxicol 89(7):1035\u20131044. https:\/\/doi.org\/10.1007\/s00204-015-1517-6","journal-title":"Arch Toxicol"},{"key":"3186_CR39","doi-asserted-by":"publisher","first-page":"931251","DOI":"10.1155\/2013\/931251","volume":"2013","author":"OO Erejuwa","year":"2013","unstructured":"Erejuwa OO, Sulaiman SA, Ab Wahab MS (2013) Evidence in support of potential applications of lipid peroxidation products in cancer treatment. Oxid Med Cell Longev 2013:931251. https:\/\/doi.org\/10.1155\/2013\/931251","journal-title":"Oxid Med Cell Longev"},{"key":"3186_CR40","doi-asserted-by":"publisher","first-page":"5406751","DOI":"10.1155\/2019\/5406751","volume":"2019","author":"JCB Ferreira","year":"2019","unstructured":"Ferreira JCB, Mori MA, Gross ER (2019) Mitochondrial bioenergetics and quality control mechanisms in health and disease. Oxid Med Cell Longev 2019:5406751. https:\/\/doi.org\/10.1155\/2019\/5406751","journal-title":"Oxid Med Cell Longev"},{"key":"3186_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/biology8020038","author":"C Chen","year":"2019","unstructured":"Chen C, Turnbull DM, Reeve AK (2019) Mitochondrial dysfunction in Parkinson\u2019s disease-cause or consequence? Biology. https:\/\/doi.org\/10.3390\/biology8020038","journal-title":"Biology"},{"key":"3186_CR42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40035-016-0060-6","volume":"5","author":"Q Hu","year":"2016","unstructured":"Hu Q, Wang G (2016) Mitochondrial dysfunction in Parkinson\u2019s disease. Transl Neurodegener 5:14. https:\/\/doi.org\/10.1186\/s40035-016-0060-6","journal-title":"Transl Neurodegener"},{"issue":"3","key":"3186_CR43","first-page":"93","volume":"6","author":"NB Madungwe","year":"2016","unstructured":"Madungwe NB, Zilberstein NF, Feng Y, Bopassa JC (2016) Critical role of mitochondrial ROS is dependent on their site of production on the electron transport chain in ischemic heart. Am J Cardiovasc Dis 6(3):93\u2013108","journal-title":"Am J Cardiovasc Dis"},{"issue":"2","key":"3186_CR44","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.bbabio.2011.10.012","volume":"1817","author":"V Giorgio","year":"2012","unstructured":"Giorgio V, Petronilli V, Ghelli A, Carelli V, Rugolo M, Lenaz G, Bernardi P (2012) The effects of idebenone on mitochondrial bioenergetics. Biochim Biophys Acta 1817(2):363\u2013369. https:\/\/doi.org\/10.1016\/j.bbabio.2011.10.012","journal-title":"Biochim Biophys Acta"},{"key":"3186_CR45","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1186\/1756-0500-4-557","volume":"4","author":"C Angebault","year":"2011","unstructured":"Angebault C, Gueguen N, Desquiret-Dumas V, Chevrollier A, Guillet V, Verny C, Cassereau J, Ferre M, Milea D, Amati-Bonneau P, Bonneau D, Procaccio V, Reynier P, Loiseau D (2011) Idebenone increases mitochondrial complex I activity in fibroblasts from LHON patients while producing contradictory effects on respiration. BMC Res Notes 4:557. https:\/\/doi.org\/10.1186\/1756-0500-4-557","journal-title":"BMC Res Notes"},{"key":"3186_CR46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.yjmcc.2019.08.010","volume":"135","author":"JB Perry","year":"2019","unstructured":"Perry JB, Davis GN, Allen ME, Makrecka-Kuka M, Dambrova M, Grange RW, Shaikh SR, Brown DA (2019) Cardioprotective effects of idebenone do not involve ROS scavenging: evidence for mitochondrial complex I bypass in ischemia\/reperfusion injury. J Mol Cell Cardiol 135:160\u2013171. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.08.010","journal-title":"J Mol Cell Cardiol"},{"issue":"9","key":"3186_CR47","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1021\/bi802282h","volume":"48","author":"MS King","year":"2009","unstructured":"King MS, Sharpley MS, Hirst J (2009) Reduction of hydrophilic ubiquinones by the flavin in mitochondrial NADH:ubiquinone oxidoreductase (Complex I) and production of reactive oxygen species. Biochemistry 48(9):2053\u20132062. https:\/\/doi.org\/10.1021\/bi802282h","journal-title":"Biochemistry"},{"key":"3186_CR48","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3389\/fphys.2017.00595","volume":"8","author":"D Ross","year":"2017","unstructured":"Ross D, Siegel D (2017) Functions of NQO1 in cellular protection and CoQ10 metabolism and its potential role as a redox sensitive molecular switch. Front Physiol 8:595. https:\/\/doi.org\/10.3389\/fphys.2017.00595","journal-title":"Front Physiol"},{"issue":"4","key":"3186_CR49","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/10715760290021270","volume":"36","author":"TS Chan","year":"2002","unstructured":"Chan TS, Teng S, Wilson JX, Galati G, Khan S, O\u2019Brien PJ (2002) Coenzyme Q cytoprotective mechanisms for mitochondrial complex I cytopathies involves NAD(P)H: quinone oxidoreductase 1(NQO1). Free Radic Res 36(4):421\u2013427. https:\/\/doi.org\/10.1080\/10715760290021270","journal-title":"Free Radic Res"},{"issue":"8","key":"3186_CR50","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.bcp.2011.12.017","volume":"83","author":"D Siegel","year":"2012","unstructured":"Siegel D, Yan C, Ross D (2012) NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones. Biochem Pharmacol 83(8):1033\u20131040. https:\/\/doi.org\/10.1016\/j.bcp.2011.12.017","journal-title":"Biochem Pharmacol"},{"key":"3186_CR51","doi-asserted-by":"publisher","first-page":"32206","DOI":"10.1038\/srep32206","volume":"6","author":"Q Zhou","year":"2016","unstructured":"Zhou Q, Chen B, Wang X, Wu L, Yang Y, Cheng X, Hu Z, Cai X, Yang J, Sun X, Lu W, Yan H, Chen J, Ye J, Shen J, Cao P (2016) Sulforaphane protects against rotenone-induced neurotoxicity in vivo: involvement of the mTOR, Nrf2, and autophagy pathways. Sci Rep 6:32206. https:\/\/doi.org\/10.1038\/srep32206","journal-title":"Sci Rep"},{"issue":"7","key":"3186_CR52","doi-asserted-by":"publisher","first-page":"e69030","DOI":"10.1371\/journal.pone.0069030","volume":"8","author":"J Kim","year":"2013","unstructured":"Kim J, Kim SK, Kim HK, Mattson MP, Hyun DH (2013) Mitochondrial function in human neuroblastoma cells is up-regulated and protected by NQO1, a plasma membrane redox enzyme. PLoS ONE 8(7):e69030. https:\/\/doi.org\/10.1371\/journal.pone.0069030","journal-title":"PLoS ONE"},{"issue":"2","key":"3186_CR53","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12031-018-1155-6","volume":"66","author":"JR Wu","year":"2018","unstructured":"Wu JR, Tuo QZ, Lei P (2018) Ferroptosis, a recent defined form of critical cell death in neurological disorders. J Mol Neurosci 66(2):197\u2013206. https:\/\/doi.org\/10.1007\/s12031-018-1155-6","journal-title":"J Mol Neurosci"},{"issue":"2","key":"3186_CR54","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, Sun B, Wang G (2020) Ferroptosis: past, present and future. Cell Death Dis 11(2):88. https:\/\/doi.org\/10.1038\/s41419-020-2298-2","journal-title":"Cell Death Dis"},{"issue":"1","key":"3186_CR55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-1326-6-8","volume":"6","author":"FP Bellinger","year":"2011","unstructured":"Bellinger FP, Bellinger MT, Seale LA, Takemoto AS, Raman AV, Miki T, Manning-Bog AB, Berry MJ, White LR, Ross GW (2011) Glutathione peroxidase 4 is associated with neuromelanin in substantia nigra and dystrophic axons in putamen of Parkinson\u2019s brain. Mol Neurodegener 6(1):8. https:\/\/doi.org\/10.1186\/1750-1326-6-8","journal-title":"Mol Neurodegener"},{"key":"3186_CR56","doi-asserted-by":"publisher","first-page":"2735492","DOI":"10.1155\/2019\/2735492","volume":"2019","author":"J Lu","year":"2019","unstructured":"Lu J, Liu X, Tian Y, Li H, Ren Z, Liang S, Zhang G, Zhao C, Li X, Wang T, Chen D, Kuang W, Zhu M (2019) Moxibustion exerts a neuroprotective effect through antiferroptosis in Parkinson\u2019s disease. Evid Based Complement Alternat Med 2019:2735492. https:\/\/doi.org\/10.1155\/2019\/2735492","journal-title":"Evid Based Complement Alternat Med"},{"issue":"4","key":"3186_CR57","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2016.10.099","volume":"480","author":"D Wang","year":"2016","unstructured":"Wang D, Peng Y, Xie Y, Zhou B, Sun X, Kang R, Tang D (2016) Antiferroptotic activity of non-oxidative dopamine. Biochem Biophys Res Commun 480(4):602\u2013607. https:\/\/doi.org\/10.1016\/j.bbrc.2016.10.099","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"3186_CR58","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1089\/ars.2009.2891","volume":"12","author":"MH Yoo","year":"2010","unstructured":"Yoo MH, Gu X, Xu XM, Kim JY, Carlson BA, Patterson AD, Cai H, Gladyshev VN, Hatfield DL (2010) Delineating the role of glutathione peroxidase 4 in protecting cells against lipid hydroperoxide damage and in Alzheimer\u2019s disease. Antioxid Redox Signal 12(7):819\u2013827. https:\/\/doi.org\/10.1089\/ars.2009.2891","journal-title":"Antioxid Redox Signal"},{"issue":"47","key":"3186_CR59","doi-asserted-by":"publisher","first-page":"28097","DOI":"10.1074\/jbc.M115.680090","volume":"290","author":"L Chen","year":"2015","unstructured":"Chen L, Hambright WS, Na R, Ran Q (2015) Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis. J Biol Chem 290(47):28097\u201328106. https:\/\/doi.org\/10.1074\/jbc.M115.680090","journal-title":"J Biol Chem"},{"key":"3186_CR60","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3389\/fphar.2018.01120","volume":"9","author":"C Li","year":"2018","unstructured":"Li C, Deng X, Xie X, Liu Y, Friedmann Angeli JP, Lai L (2018) Activation of glutathione peroxidase 4 as a novel anti-inflammatory strategy. Front Pharmacol 9:1120. https:\/\/doi.org\/10.3389\/fphar.2018.01120","journal-title":"Front Pharmacol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03186-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-020-03186-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03186-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T10:48:15Z","timestamp":1614077295000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-020-03186-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,28]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["3186"],"URL":"https:\/\/doi.org\/10.1007\/s11064-020-03186-w","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,28]]},"assertion":[{"value":"29 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Experiments involved in this study conducted under the permission of the Animals Ethics Committee of Ondokuz May\u0131s University (HADYEK 2018_49). All experiments were carefully performed to reduce animal suffering by following the Guide of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}